A new hope for
Valley Fever Treatment

Hot, Dry Summers
Exposure to Dust
Inhaling Fungal Spores
Valley Fever

A fungal threat that needs better therapeutic solutions

Valley fever, also known as Coccidioidomycosis, is a fungal infection caused by inhaling spores of Coccidioides fungi. It primarily strikes people living in the Southwestern United States and parts of Mexico and Central and South America. This region, characterized by hot, dry summers and mild winters, provides the ideal environment for the fungus to thrive in soil. The disease disproportionately affects the immune suppressed. However, anyone living in endemic areas is at risk.

See CDC Valley Fever maps and discussion

150,000
people contract Valley fever annually. Many more are undiagnosed
60,000
experience symptoms serious enough to seek medical attention
2,000
require hospitalization, and tragically, about 150 succumb to the disease

A rare but devastating disease

Worst of all, the risks of infection are increasing as more people move to the endemic areas of California and Arizona for retirement, more people have other diseases or take drugs that slow the immune system, and there are simply more people over 60 with a higher risk of infection. Another concern is the disproportionately high number of cases that go undiagnosed due in part to people without ready access to care, or people with initially mild cases that put off seeking care.

TIME FOR CHANGE

Better treatment is needed for Valley Fever. It’s ready for final development. It’s time.

LET’S TALK